Navigation Links
US Oncology Announces Realignment of Executive Team
Date:1/25/2008

HOUSTON, Jan. 25 /PRNewswire/ -- Today, the Board of Directors of US Oncology Holdings, Inc. and its wholly owned subsidiary US Oncology, Inc. (collectively, "US Oncology" or the "Company") announced that, effective February 1, 2008, Dale Ross will transition out of his role as Chief Executive Officer (CEO) and will continue as the Executive Chairman of the Company. At that time, Bruce D. Broussard will become the Company's President and CEO. The CEO transition is a planned succession that follows Broussard's promotion to President in November 2005. Broussard was also elected to the Company's Board of Directors, effective February 1.

"For the past seven years, Bruce and I have worked together to build and strengthen our network and deliver value to our stakeholders," said Ross. "We will continue to fulfill the network mission to increase access to and advance the delivery of high-quality cancer care in America, with Bruce leading the day-to-day operations. It has been gratifying for me to work with Bruce and watch him grow into an exceptional leader and manager. His passion for execution, coupled with his vision and strategic prowess, will prove invaluable in these challenging, but opportune, times."

"It has been remarkable to be part of Dale's team at US Oncology. I feel fortunate to have learned from a CEO whom I, along with leaders throughout our network, greatly admire. I look forward to continuing our working relationship as he becomes Executive Chairman and we continue to develop our network and deliver on our commitment to excellence," said Broussard.

Ross has served as US Oncology's CEO and a member of the board of directors since the Company's inception in 1992. In his role as Executive Chairman, Ross will remain actively involved in the business of the Company, but will be relinquishing operational duties. This will allow his full attention to be focused on guiding long-term strategic opportunities for the Company, enhancing eng
'/>"/>

SOURCE US Oncology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Oncology Metrics and E-Expert Reimbursement Partners Announce Joint Marketing and Product Development Agreement
2. ProCure Selects IMPAC as Provider of Oncology Information Systems
3. Advanced Medical Specialties Joins US Oncology Network
4. Oncology Metrics and Cureline Announce Joint Marketing Agreement
5. Center for Molecular Medicine Selected to Provide DNA Analysis for Childrens Oncology Group Leukemia Study
6. Quest PharmaTech to Receive $3,000,000 to Develop Oncology Products Based on its SonoLight Technology
7. AG Mednet to Provide Image Network for Southwest Oncology Group
8. IMPAC Medical Systems to Offer Revenue Cycle Inc.s Array of Oncology Products and Services to Customers
9. PRA International to Present Audioconference on Oncology Research - Nov. 8
10. Pharsight Invited to Present on Oncology Modeling and Simulation at Quantitative Pharmacology Symposium in China
11. Ranbaxy to Consolidate Position in Biopharmaceuticals and Speciality Injectables Including Oncology

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... , REYKJAVIK, Iceland, Novemb...nc. (Nasdaq: DCGN ) today announced the approval o...uptcy Court for the District of Delaware,(the "Ban...y petition for,relief under Chapter 11 of the Unit...t. , The orders issued by the Bankruptcy ...
(Date:11/24/2009)... , SHANGHAI, Nov. 24 /PRNewswire-Asia...Food & Drug Administration (SFDA) has approved...r its oral insulin project,(Nodlin), an innovative...pproval allows Biolaxy to initiate its first phase...er characteristic of high blood glucose and poor,m...
(Date:11/24/2009)... , , Primary efficacy endpoint has been me...t endometrial cancer, , QUEBEC CITY, Nov. 24 ...SDAQ: AEZS ; TSX: AEZ) (the "Company"), a global ...rapy and oncology, today announced positive effica...otoxic peptide conjugate, AEZS-108 (formerly AN-15...
(Date:11/24/2009)... , SAN DIEGO, Nov. 24, 2009 /PRNewswire-Fi...ARNA ) announced today that the company is sched...ealth Care Conference on December 1, 2009 at 11:30... New York Palace Hotel in New York City. Jack Lief...s scheduled to provide an overview of the company,...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 3
...ion of,North America and its partner Helsinn Healt...ug Administration (FDA) has approved a new oral,fo... for the prevention of,chemotherapy-induced nausea...al administration is indicated for the prevention ... repeat courses of moderately emetogenic,chemother...
...-- WuXi PharmaTech (NYSE:,WX), a leading pharmaceu...nd development outsourcing company with operations...hat it has promoted Dr. Rujian Ma to Vice,Presiden...scom.com/cgi-bin/prnh/20040705/CNM002LOGO ), Dr.... Scientific,Officer of WuXi PharmaTech., "I am ve...
...e-FirstCall/ - OncoGenex,Pharmaceuticals (NASDAQ: ...s,custirsen sodium, received Fast Track designatio...n combination with docetaxel for progressive,metas...ting five Phase 2,clinical studies in prostate, lu...he production of a specific protein, clusterin, as...
Other Biology Technology:FDA Approves ALOXI(R) (Palonosetron HCl) Capsules for Prevention of Acute Chemotherapy-induced Nausea and Vomiting 2FDA Approves ALOXI(R) (Palonosetron HCl) Capsules for Prevention of Acute Chemotherapy-induced Nausea and Vomiting 3WuXi PharmaTech Promotes Dr. Rujian Ma to VP of Synthetic Chemistry 2FDA Grants Fast Track Designation for OncoGenex Pharmaceuticals' Lead Product Candidate OGX-011 2FDA Grants Fast Track Designation for OncoGenex Pharmaceuticals' Lead Product Candidate OGX-011 3FDA Grants Fast Track Designation for OncoGenex Pharmaceuticals' Lead Product Candidate OGX-011 4
(Date:11/24/2009)...search on bacterial communities throughout six lar...poral patterns, suggesting that scientists could u...mate change in the polar regions. The study, publi... Academy of Sciences Early Edition, shows that ba...hronously over time, correlating with seasonal shi...
(Date:11/23/2009)...dence that the "synergistic" effect of early-life ... and indoor endotoxin causes more harm to developi..., Environmental health scientists at the Universi...wn that children exposed to both high levels of tr...g early life are six times more likely to experien...
(Date:11/23/2009)...pplied mathematicians dissected the morphology of ...ristic long leaf with a saddle-like arc midsection...imple cause of the lily,s fan-like shapeelastic re...l growthwas revealed by using an equally simple te... a postdoctoral student at Harvard,s School of Eng...
Breaking Biology News(10 mins):Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2The cause behind the characteristic shape of a long leaf revealed 2Obama Administration Advances Long Term Services and Supports in Health Care Reform 50938 1Obama Administration Advances Long Term Services and Supports in Health Care Reform 50938 2ICSI Plans Symposium on New Depression Treatment Program That Is Improving Patient Outcomes Five Fold Over Typical Primary Care 50936 1ICSI Plans Symposium on New Depression Treatment Program That Is Improving Patient Outcomes Five Fold Over Typical Primary Care 50936 2Genes Linked to Cholesterol in Cells Are Identified 50935 1Genes Linked to Cholesterol in Cells Are Identified 50935 2
...sh are no strangers to Americans. From the comedic...hildren,s Disney favorite, "Nemo," fish can talk, ...he silver screen. But can real fish verbally commu...ed in the July 18 issue of the journal Science . ... communications of all vertebrates--in evolutionar...
...HI A new indicator of coral health has been disco...algae called dinoflagellates. The study, released ...s of the National Academy of Sciences, reveals th... more susceptible to disease. , "Corals are fasc...inoflagellates that live inside the coral,s tissue...
... way from the dull hums of the amorous midshipman ...ven to the simplest Celine Dion melody. But the ne...t to mention birdsongs, frog thrums and mating cal...own hundreds of millions of years ago with the hum...e developing brain cells in newly hatched midshipm...
Other Biology News:New indicator uncovered that can predict coral health 2New indicator uncovered that can predict coral health 3From humming fish to Puccini: Vocal communication evolved with ancient species 2
...product has been developed to significantly increa...oteins. Stability is increased at room temperatur.... This product is subjected to 0.2 micron filtrat...lation insures consistently high levels of activit...
Corning brand cover glass squares, 0.16 to 0.19mm thick from Sigma-Aldrich
...uropean Collection of Cell Cultures (ECACC) has be...y, academia and government institutes for over sev...troduce candidates to cell culture and a Level II ... as planning and management of a cell culture labo...
DU 530 Life Science UV/Visible Spectrophotometers from Beckman Coulter
Biology Products: